SEC Form 4 · accession 0001209191-17-014908
MELINTA THERAPEUTICS, INC. /NEW/ · MLNT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David W. Oldach
Officer — Chief Medical Officer
Period of report
Feb 23, 2017
Accepted (ET)
Feb 27, 2017 · 5:32 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001461993
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 1,100 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F1 | $3.15 | Feb 23, 2017 | A | 25,000 | A | — | Feb 22, 2027 | Common Stock | 25,000 | 25,000 | D |
| Restricted Stock UnitsF2,F3 | — | Feb 23, 2017 | A | 25,000 | A | — | — | Common Stock | 25,000 | 25,000 | D |
| Employee Stock Option (Right to Buy)F4 | $23.51 | holding | — | — | — | — | Dec 31, 2024 | Common Stock | 23,000 | 23,000 | D |
| Employee Stock Option (Right to Buy)F5 | $13.10 | holding | — | — | — | — | Jan 7, 2024 | Common Stock | 7,500 | 7,500 | D |
| Employee Stock Option (Right to Buy)F6 | $6.64 | holding | — | — | — | — | Mar 6, 2023 | Common Stock | 10,000 | 10,000 | D |
| Employee Stock Option (Right to Buy)F7 | $6.63 | holding | — | — | — | — | Jan 17, 2023 | Common Stock | 14,087 | 14,087 | D |
| Employee Stock Option (Right to Buy)F8 | $7.47 | holding | — | — | — | — | Mar 20, 2022 | Common Stock | 20,000 | 20,000 | D |
| Employee Stock Option (Right to Buy)F9 | $2.28 | holding | — | — | — | — | Feb 28, 2021 | Common Stock | 8,222 | 18,125 | D |
| Employee Stock Option (Right to Buy)F9 | $2.28 | holding | — | — | — | — | Feb 28, 2021 | Common Stock | 1,778 | 16,347 | D |
| Employee Stock Option (Right to Buy)F10 | $31.13 | holding | — | — | — | — | Dec 31, 2025 | Common Stock | 45,893 | 45,893 | D |
| Employee Stock Option (Right to Buy)F11 | $3.00 | holding | — | — | — | — | Jan 2, 2027 | Common Stock | 125,000 | 125,000 | D |
| Restricted Stock UnitsF2,F3 | — | holding | — | — | — | — | — | Common Stock | 50,000 | 50,000 | D |
Explanation of responses
- F1The option vests according to the following schedule: 1/48th of the shares vest at the end of each month over 48 months, beginning after 02/23/2017.
- F10The option vests according to the following schedule: 1/48th of the shares vest at the end of each month over 48 months, beginning after January 1, 2016.
- F11The option vests according to the following schedule: 1/48th of the shares shall vest at the end of each month over 48 months, beginning after 01/01/2017.
- F2Each restricted stock unit represents a contingent right to receive one share of Cempra, Inc. common stock.
- F3The restricted stock units vest in full on January 1, 2019, subject to continued employment, or upon termination without cause.
- F4The option vests according to the following schedule: 1/48th of the shares vest at the end of each month over 48 months, beginning after 01/01/2015.
- F5The option vests according to the following schedule: 1/48th of the shares vest at the end of each month over 48 months, beginning after 01/01/2014.
- F6The option vested according to the following schedule: 1/4th of the shares vest at the end of each quarter, beginning after 01/01/2013.
- F7The option vested according to the following schedule: 1/4th of the shares vest at the end of each quarter, beginning after 01/01/2013.
- F8The option vested on the one-year anniversary of the 03/21/2012 grant date.
- F9The option vests according to the following schedule: 1/4th of the shares vest on the one-year anniversary of the 03/01/2011 grant date; 1/36th of the remaining shares vest at the end of each month over the next 36 months.